Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...
billboard hot 100™ the week’s most popular current songs across all genres, ranked by streaming activity from digital music sources tracked by luminate, radio airplay audience impressions as ...